We represented PANTHERx, a specialty pharmacy specializing in orphan drugs and rare diseases, in its sale to Centene Corporation, a diversified, multi-national healthcare enterprise that provides a portfolio of services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Terms of the transaction were not disclosed.
PANTHERx Sells to Centene
Client Type: Private Company
You Also May Be Interested In:
-
Advise a public university system on compliance with the rules associated with grants and contracts from NIH, NSF, and the Department of Defense
-
Representation of Parthenon Capital, a growth-oriented private equity firm, as healthcare regulatory counsel in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers
-
Representation of Lead Capital Partners, a multi-family sponsored private equity firm, in its acquisition of Ladd Dental Group, Inc., a dental service provider with six locations throughout central Indiana